Cargando…

Psoralen Inactivation of Viruses: A Process for the Safe Manipulation of Viral Antigen and Nucleic Acid

High consequence human pathogenic viruses must be handled at biosafety level 2, 3 or 4 and must be rendered non-infectious before they can be utilized for molecular or immunological applications at lower biosafety levels. Here we evaluate psoralen-inactivated Arena-, Bunya-, Corona-, Filo-, Flavi- a...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Katherine, Wronka-Edwards, Loni, Leggett-Embrey, Melissa, Walker, Eric, Sun, Peifang, Ondov, Brian, Wyman, Travis H., Rosovitz, MJ, Bohn, Sherry S., Burans, James, Kochel, Tadeusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664985/
https://www.ncbi.nlm.nih.gov/pubmed/26569291
http://dx.doi.org/10.3390/v7112912
Descripción
Sumario:High consequence human pathogenic viruses must be handled at biosafety level 2, 3 or 4 and must be rendered non-infectious before they can be utilized for molecular or immunological applications at lower biosafety levels. Here we evaluate psoralen-inactivated Arena-, Bunya-, Corona-, Filo-, Flavi- and Orthomyxoviruses for their suitability as antigen in immunological processes and as template for reverse transcription PCR and sequencing. The method of virus inactivation using a psoralen molecule appears to have broad applicability to RNA viruses and to leave both the particle and RNA of the treated virus intact, while rendering the virus non-infectious.